Work

Critical need for pharmacologic treatment options in NAFLD: A pediatric perspective

Year: 2021

Type: article

Abstract: Nonalcoholic fatty liver disease (NAFLD) affects up to 70% of children with obesity and has become the number one etiology for liver transplant in the United States. Early, effective intervention is critical to prevent disease progression into adulthood. Yet, it is seldom achieved through lifestyle modification alone. Thus, children must be included in NAFLD pharmacology trials, which, to date, continue to focus primarily on adult populations. This commentary serves as a call to action.

Source: Clinical and Translational Science

DOI: 10.1111/cts.12952

Authors: Chance S. Friesen, Sherwin S. Chan, Jonathan B. Wagner, Chelsea Hosey‐Cojocari, Iván L. Csanaky, Valentina Shakhnovich

Institutions: University of Kansas, University of Missouri–Kansas City, University of Kansas Medical Center

Language: English

Topic: Liver Disease Diagnosis and Treatment

Subfield: Epidemiology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

Estimated APC paid: $3,300